Ten years of rizatriptan: From development to clinical science and future directions

Richard J. Hargreaves, Chris R. Lines, Alan M. Rapoport, Tony W. Ho, Fred D. Sheftell

Research output: Contribution to journalReview article

Abstract

The year 2008 marked the 10th anniversary since rizatriptan was first launched for the acute treatment of migraine. In this article we discuss the concepts that motivated the preclinical and clinical development of rizatriptan, the clinical evidence that has driven its use over the past decade, rizatriptan's overall contribution to the field, and future directions for research.

Original languageEnglish (US)
Pages (from-to)S3-S20
JournalHeadache
Volume49
Issue numberSUPPL. 1
DOIs
StatePublished - Feb 1 2009

    Fingerprint

Keywords

  • Clinical science
  • Development
  • Rizatriptan

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Hargreaves, R. J., Lines, C. R., Rapoport, A. M., Ho, T. W., & Sheftell, F. D. (2009). Ten years of rizatriptan: From development to clinical science and future directions. Headache, 49(SUPPL. 1), S3-S20. https://doi.org/10.1111/j.1526-4610.2008.01335.x